K Pharma,Inc. (TYO:4896)

K Pharma,Inc. Statistics

Total Valuation

K Pharma,Inc. has a market cap or net worth of JPY 10.11 billion. The enterprise value is 8.82 billion.

Market Cap	10.11B
Enterprise Value	8.82B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

K Pharma,Inc. has 11.61 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	11.61M
Shares Outstanding	11.61M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	43.07%
Owned by Institutions (%)	2.79%
Float	1.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.99
P/TBV Ratio	7.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.88
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.50

Financial Position

The company has a current ratio of 28.61, with a Debt / Equity ratio of 1.19.

Current Ratio	28.61
Quick Ratio	27.63
Debt / Equity	1.19
Debt / EBITDA	n/a
Debt / FCF	-1.61
Interest Coverage	-130.86

Financial Efficiency

Return on equity (ROE) is -56.37% and return on invested capital (ROIC) is -118.50%.

Return on Equity (ROE)	-56.37%
Return on Assets (ROA)	-21.64%
Return on Invested Capital (ROIC)	-118.50%
Return on Capital Employed (ROCE)	-32.28%
Weighted Average Cost of Capital (WACC)	5.10%
Revenue Per Employee	n/a
Profits Per Employee	-58.41M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, K Pharma,Inc. has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.18% in the last 52 weeks. The beta is 0.28, so K Pharma,Inc.'s price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+31.18%
50-Day Moving Average	719.88
200-Day Moving Average	702.02
Relative Strength Index (RSI)	64.29
Average Volume (20 Days)	169,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-916.00M
Pretax Income	-991.00M
Net Income	-993.00M
EBITDA	n/a
EBIT	-916.00M
Earnings Per Share (EPS)	-85.57

Balance Sheet

The company has 2.79 billion in cash and 1.50 billion in debt, with a net cash position of 1.29 billion or 111.20 per share.

Cash & Cash Equivalents	2.79B
Total Debt	1.50B
Net Cash	1.29B
Net Cash Per Share	111.20
Equity (Book Value)	1.27B
Book Value Per Share	109.00
Working Capital	2.79B

Cash Flow

In the last 12 months, operating cash flow was -918.00 million and capital expenditures -11.00 million, giving a free cash flow of -929.00 million.

Operating Cash Flow	-918.00M
Capital Expenditures	-11.00M
Free Cash Flow	-929.00M
FCF Per Share	-80.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

K Pharma,Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-9.82%
FCF Yield	-9.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1